About the Center for Integrative Cardiovascular and Metabolic Diseases

The Center for Integrative Cardiovascular and Metabolic Diseases was originally named the Hypertension Center and was created in 1992 by the Board of Regents and Dr. Christopher Wilcox, then Division Chief of Nephrology at the VAMC.  Dr. Wilcox became the inaugural director.  When Dr. Wilcox left in 1995, Dr. Ian Phillips, then chair of Physiology and Functional Genomics, took over as director until he left the University of Florida in 2002.  In July of 2004, the Department of Physiology and Functional Genomics recruited Dr. Christine Baylis to the University of Florida to serve as Center Director.  The Center benefited from the outstanding leadership and vision of Dr. Baylis for more than a decade until her retirement in 2015.

Given the strong presence that Dr. Baylis had in the field of hypertension, it is perhaps not surprising, that a multi-directorship model was needed to replace her leadership.  The directorship has transitioned to Dr. Eric Krause, Ph.D., Associate Professor of Pharmacodynamics in the UF College of Pharmacy: (click here for more information).